- Home
- NEGG vs LUNG Comparison
NEGG vs LUNG Comparison
Compare NEGG & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- LUNG
- Stock Information
- Founded
- NEGG 2001
- LUNG 1995
- Country
- NEGG United States
- LUNG United States
- Employees
- NEGG N/A
- LUNG N/A
- Industry
- NEGG Other Specialty Stores
- LUNG Industrial Specialties
- Sector
- NEGG Consumer Discretionary
- LUNG Health Care
- Exchange
- NEGG Nasdaq
- LUNG Nasdaq
- Market Cap
- NEGG 122.3M
- LUNG 106.3M
- IPO Year
- NEGG 2010
- LUNG 2020
- Fundamental
- Price
- NEGG $64.68
- LUNG $1.73
- Analyst Decision
- NEGG
- LUNG Buy
- Analyst Count
- NEGG 0
- LUNG 7
- Target Price
- NEGG N/A
- LUNG $7.66
- AVG Volume (30 Days)
- NEGG 1.3M
- LUNG 743.5K
- Earning Date
- NEGG 08-28-2025
- LUNG 07-30-2025
- Dividend Yield
- NEGG N/A
- LUNG N/A
- EPS Growth
- NEGG N/A
- LUNG N/A
- EPS
- NEGG N/A
- LUNG N/A
- Revenue
- NEGG $1,235,576,000.00
- LUNG $90,549,000.00
- Revenue This Year
- NEGG N/A
- LUNG $17.92
- Revenue Next Year
- NEGG N/A
- LUNG $18.56
- P/E Ratio
- NEGG N/A
- LUNG N/A
- Revenue Growth
- NEGG N/A
- LUNG 18.24
- 52 Week Low
- NEGG $3.32
- LUNG $1.59
- 52 Week High
- NEGG $69.50
- LUNG $9.37
- Technical
- Relative Strength Index (RSI)
- NEGG 67.17
- LUNG 29.04
- Support Level
- NEGG $25.49
- LUNG $3.03
- Resistance Level
- NEGG $69.50
- LUNG $3.39
- Average True Range (ATR)
- NEGG 9.01
- LUNG 0.33
- MACD
- NEGG 2.65
- LUNG -0.17
- Stochastic Oscillator
- NEGG 89.05
- LUNG 2.62
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.